Implantable Medical Device Exposure Mode Telemetry Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Implantable medical devices (IMDs) face undesirable operation when exposed to disruptive energy fields, such as those from MRI scans, leading to inappropriate therapy delivery or withholding due to induced energy on leads, which can result in heating and compromised pacing and sensing thresholds.
Innovation Solution
The implementation of a telemetry system that periodically transmits signals indicating the presence of a disruptive energy field, allowing the IMD to transition into an exposure operating mode, which is less susceptible to these issues, and revert back to normal operation when the field is no longer detected.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If the IMD operates in normal mode, then therapy delivery is optimized for patient treatment, but the device becomes susceptible to induced energy from disruptive fields causing inappropriate operation
Solution Approach 1:
The IMD dynamically transitions between normal operating mode and exposure mode based on detection of disruptive energy fields. The device adjusts its operational state in real-time, switching parameters such as sensing thresholds and therapy delivery settings to appropriate configurations for the current environmental condition, thereby maintaining reliability across varying operational contexts
Solution Approach 2:
The device applies preliminary protective measures by detecting the presence of disruptive energy fields before they can cause harmful effects. Upon detection, the IMD preemptively adjusts its sensing and therapy parameters to prevent inappropriate operation, heating, or threshold compromise, countering potential harm before it occurs
2Object-affected harmful factors
If the IMD enters exposure mode to reduce susceptibility to induced energy, then safety during disruptive field exposure is improved, but therapy efficacy may be compromised due to mode transitions
Solution Approach 1:
The device employs dynamic mode switching with predetermined transition criteria, allowing it to adapt to disruptive field conditions while maintaining therapy efficacy through controlled parameter adjustments. The system monitors field presence continuously and transitions modes based on sustained detection thresholds, preventing premature or unnecessary mode changes that could compromise therapy consistency
Solution Approach 2:
The IMD uses feedback mechanisms to monitor both the disruptive field presence and the effectiveness of therapy delivery in each operating mode. Based on this feedback, the device adjusts its operation to maintain therapeutic goals while protected from harmful effects, ensuring that mode transitions occur only when beneficial and do not undermine treatment efficacy
3Reliability
If the IMD continuously monitors for telemetry signals indicating disruptive field presence, then safety is improved through timely mode transitions, but energy consumption increases
Solution Approach 1:
The IMD implements periodic monitoring of telemetry signals at predetermined intervals rather than continuous monitoring. The device checks for the presence of disruptive energy fields at scheduled times, transitioning to exposure mode only when signals are detected, thereby reducing unnecessary energy consumption while maintaining adequate safety monitoring
Solution Approach 2:
The monitoring frequency and depth are dynamically adjusted based on environmental context and device state. The device intensifies monitoring when risk factors are present and reduces monitoring intensity during low-risk periods, optimizing the balance between safety assurance and energy conservation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This solution enables IMDs to operate more reliably and safely during exposure to disruptive energy fields by reducing adverse effects like heating and incorrect therapy delivery, ensuring consistent therapy efficacy.
Implementation Method 1
A telemetry device may be configured to periodically transmit telemetry signals indicating presence of a source of a disruptive energy field
Implementation Method 2
The disruptive energy field may induce energy on one or more of the implantable leads coupled to the IMD
Implementation Method 3
the induced energy on the leads may result in heating of the tissue and/or nerve site adjacent to the electrodes of the leads
Data Source
AI summary
This disclosure describes techniques for enabling and/or disabling an exposure operating mode using telemetry signals. A telemetry device may be configured to periodically transmit telemetry signals indicating presence of a source of a disruptive energy field in accordance with a communication protocol. An implantable medical device may be configured to receive the telemetry signals from the telemetry device and enter the exposure operating mode in response to receiving a first one of the telemetry signals indicating the presence of the source of the disruptive energy field. The implantable medical device may also exit the exposure operating mode in response to not receiving any of telemetry signals indicating the presence of the source of the disruptive energy field for a predetermined period of time.